Current Value
$780.461 Year Return
Current Value
$780.461 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AIFU | -11.74% | $6.79B | +102.19% | 0.00% |
| AGL | -11.57% | $989.35M | -60.10% | 0.00% |
| LTM | -11.54% | $12.63B | -95.46% | 2.42% |
| UNH | -11.03% | $279.00B | -37.22% | 2.74% |
| CPSH | -10.05% | $42.27M | +74.25% | 0.00% |
| UUU | -9.88% | $7.17M | +101.30% | 0.00% |
| CMP | -9.31% | $916.48M | +110.72% | 0.00% |
| TDUP | -7.93% | $895.13M | +358.79% | 0.00% |
| GHG | -7.64% | $162.90M | -2.79% | 0.00% |
| RLMD | -7.57% | $19.95M | -80.03% | 0.00% |
| UPBD | -6.74% | $1.52B | -12.30% | 5.80% |
| CNK | -5.98% | $3.47B | +41.29% | 0.53% |
| VSA | -5.77% | $8.67M | -19.04% | 0.00% |
| DFDV | -5.61% | $300.56M | +2,130.16% | 0.00% |
| KELYA | -5.46% | $433.35M | -43.19% | 2.43% |
| CABO | -5.32% | $766.56M | -61.04% | 6.49% |
| AQB | -4.11% | $2.96M | -53.35% | 0.00% |
| MKTX | -3.89% | $8.22B | +9.03% | 1.38% |
| FDP | -3.84% | $1.59B | +52.62% | 3.31% |
| FROG | -3.76% | $4.74B | +15.86% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IHE | 76.14% | $550.45M | 0.39% |
| PPH | 68.93% | $610.46M | 0.36% |
| IXJ | 62.59% | $3.75B | 0.41% |
| IYH | 61.70% | $2.73B | 0.39% |
| VHT | 60.96% | $15.35B | 0.09% |
| XLV | 60.73% | $34.28B | 0.09% |
| FHLC | 60.65% | $2.44B | 0.084% |
| PINK | 54.65% | $130.57M | 0.5% |
| XPH | 49.03% | $147.96M | 0.35% |
| BBH | 48.79% | $330.62M | 0.35% |
| PTH | 48.31% | $100.85M | 0.6% |
| DUHP | 48.00% | $8.66B | 0.21% |
| IBB | 47.67% | $5.26B | 0.45% |
| QUAL | 45.70% | $52.99B | 0.15% |
| IHI | 45.70% | $4.62B | 0.4% |
| XBI | 45.65% | $4.82B | 0.35% |
| FXH | 45.51% | $903.07M | 0.62% |
| QUS | 45.16% | $1.58B | 0.15% |
| FBT | 45.00% | $1.01B | 0.54% |
| BBLU | 44.94% | $276.64M | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IMDX | 0.02% | $86.94M | -0.65% | 0.00% |
| MVO | 0.06% | $66.47M | -37.17% | 21.45% |
| MITK | 0.07% | $466.12M | -9.95% | 0.00% |
| ACDC | 0.08% | $1.27B | +3.52% | 0.00% |
| ASTH | 0.08% | $1.23B | -38.25% | 0.00% |
| PARR | 0.09% | $1.54B | +15.71% | 0.00% |
| SAFT | 0.09% | $1.14B | +1.96% | 4.71% |
| HUSA | 0.10% | $19.66M | -19.53% | 0.00% |
| LITB | 0.12% | $21.24M | -78.57% | 0.00% |
| AGCO | -0.14% | $8.25B | +14.36% | 1.05% |
| MSEX | 0.19% | $1.00B | +5.97% | 2.41% |
| VSTA | 0.20% | $344.07M | +39.29% | 0.00% |
| SPOK | -0.22% | $358.16M | +15.76% | 7.20% |
| PLL | 0.23% | $145.28M | -36.04% | 0.00% |
| EVGO | 0.24% | $470.93M | +38.74% | 0.00% |
| TR | 0.25% | $2.57B | +22.68% | 1.02% |
| CWCO | 0.26% | $492.46M | +26.08% | 1.51% |
| IRBT | -0.29% | $99.85M | -63.89% | 0.00% |
| WMK | 0.35% | $2.03B | +21.81% | 1.81% |
| PARAA | -0.35% | $15.57B | +14.88% | 0.87% |
SeekingAlpha
Growth stocks led a furious market rebound from tariff uncertainty with the higher-beta technology and communication services sectors leading in the return to a risk-on environment.
Yahoo
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
SeekingAlpha
June's labor market exceeded expectations, but Fed projections and trade tariffs loom. Check out why I think healthcare stocks could make some of the best buys.
Yahoo
Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating and $1,050 price target on Eli Lilly & Company (NYSE:LLY), pointing to the pharmaceutical company’s dominant position in the market for treating obesity. Sales estimates for Eli Lilly & Company (NYSE:LLY)’s weight-loss treatment Zepbound […]
Yahoo
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with Lilly and Novo.
Yahoo
Novo Nordisk A/S’ (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its obesity drug Wegovy. As rival Eli Lilly and Co.’s (NYSE:LLY) Zepbound gains momentum, the Danish pharmaceutical giant is ...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| COST | 45.76% | $435.65B | +13.88% | 0.49% |
| AZN | 45.20% | $220.60B | -7.38% | 2.19% |
| ALNY | 43.23% | $43.00B | +32.61% | 0.00% |
| GEHC | 42.53% | $34.85B | -1.45% | 0.17% |
| SPGI | 42.23% | $161.21B | +16.95% | 0.71% |
| ALC | 42.12% | $44.17B | +1.33% | 0.38% |
| FOLD | 41.36% | $1.83B | -39.35% | 0.00% |
| HROW | 41.34% | $1.12B | +41.49% | 0.00% |
| MCO | 40.85% | $89.43B | +16.70% | 0.72% |
| NVO | 40.83% | $235.02B | -49.72% | 2.40% |
| AVB | 40.63% | $28.76B | +0.52% | 3.41% |
| SYK | 40.13% | $149.74B | +18.01% | 0.85% |
| BSX | 39.96% | $153.32B | +36.16% | 0.00% |
| SKT | 39.93% | $3.55B | +19.96% | 3.56% |
| AMRX | 39.89% | $2.62B | +24.00% | 0.00% |
| CPRX | 39.86% | $2.62B | +40.10% | 0.00% |
| ECL | 39.40% | $77.25B | +15.52% | 0.92% |
| IQV | 39.34% | $28.48B | -20.39% | 0.00% |
| RWT | 38.55% | $817.34M | -4.81% | 11.54% |
| ISRG | 38.39% | $193.76B | +24.33% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| UGA | 0.07% | $72.33M | 0.97% |
| IBTH | -0.08% | $1.62B | 0.07% |
| BILS | -0.13% | $3.81B | 0.1356% |
| USDU | 0.25% | $162.43M | 0.5% |
| BILZ | -0.27% | $821.74M | 0.14% |
| WEAT | -0.35% | $117.15M | 0.28% |
| STOT | -0.43% | $254.07M | 0.45% |
| SPSK | 0.54% | $321.02M | 0.5% |
| IBTI | 0.56% | $1.06B | 0.07% |
| IBTF | -0.71% | $1.99B | 0.07% |
| IBTJ | 0.71% | $688.19M | 0.07% |
| BWX | 0.73% | $1.53B | 0.35% |
| SHYM | -0.81% | $357.13M | 0.35% |
| UNG | 0.90% | $360.54M | 1.06% |
| CANE | -1.05% | $10.37M | 0.29% |
| IEI | 1.29% | $15.48B | 0.15% |
| LDUR | 1.51% | $929.65M | 0.5% |
| ASHR | 1.68% | $1.91B | 0.65% |
| UDN | -1.79% | $148.33M | 0.78% |
| IBTK | 2.04% | $448.89M | 0.07% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -36.71% | $164.54M | 0.85% |
| TAIL | -36.49% | $99.63M | 0.59% |
| TPMN | -31.65% | $30.70M | 0.65% |
| BTAL | -19.34% | $296.22M | 1.43% |
| XONE | -12.78% | $625.28M | 0.03% |
| IVOL | -10.47% | $347.03M | 1.02% |
| XHLF | -9.25% | $1.73B | 0.03% |
| TBLL | -8.83% | $2.13B | 0.08% |
| FTSD | -8.77% | $231.81M | 0.25% |
| SPTS | -7.77% | $5.80B | 0.03% |
| GBIL | -7.50% | $6.37B | 0.12% |
| XBIL | -6.34% | $783.90M | 0.15% |
| ULST | -5.63% | $654.75M | 0.2% |
| IBTG | -5.60% | $1.92B | 0.07% |
| FXE | -5.48% | $568.94M | 0.4% |
| CORN | -4.42% | $44.67M | 0.2% |
| SOYB | -4.28% | $26.67M | 0.22% |
| BIL | -3.80% | $42.24B | 0.1356% |
| CLIP | -3.24% | $1.51B | 0.07% |
| UTWO | -3.23% | $379.52M | 0.15% |
Double maintains 14 strategies that include LLY - Eli Lilly & Co.
